Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of ADXS11-001 in Subjects With Persistent/Recurrent, Loco-Regional or Metastatic Squamous Cell Carcinoma of the Anorectal Canal

NCT02399813 is registered in ClinicalTrials.gov with Advaxis, Inc. as lead sponsor.

NCT NCT02399813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02399813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of ADXS11-001 in Subjects With Persistent/Recurrent, Loco-Regional or Metastatic Squamous Cell Carcinoma of the Anorectal Canal
Lead sponsor
Advaxis, Inc.
Phase
Phase 2
Overall status
Completed
Start date
June 2, 2016
Completion date
January 3, 2019
Enrollment
36 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer, rectal cancer